Inadvertent yellow fever vaccination of a patient with Crohn's disease treated with infliximab and methotrexate.

about

Inadvertent yellow fever vaccination of a patient with Crohn's disease treated with infliximab and methotrexate.

Item

http://www.wikidata.org/entity/Q38559337

description

2016 nî lūn-bûn

@nan

2016年の論文

@ja

2016年論文

@yue

2016年論文

@zh-hant

2016年論文

@zh-hk

2016年論文

@zh-mo

2016年論文

@zh-tw

2016年论文

@wuu

2016年论文

@zh

2016年论文

@zh-cn

name

Inadvertent yellow fever vacci ...... h infliximab and methotrexate.

@en

type

Item

label

Inadvertent yellow fever vacci ...... h infliximab and methotrexate.

@en

prefLabel

Inadvertent yellow fever vacci ...... h infliximab and methotrexate.

@en

P1476

Inadvertent yellow fever vacci ...... h infliximab and methotrexate.

@en

P2093

Christina Ekenberg

http://www.w3.org/2001/XMLSchema#string

Claus Aalykke

http://www.w3.org/2001/XMLSchema#string

Nina Friis-Møller

http://www.w3.org/2001/XMLSchema#string

Thomas Ulstrup

http://www.w3.org/2001/XMLSchema#string

P2860

Determinants of health-related quality of life in Crohn's disease: a systematic review and meta-analysis.

Efficacy and duration of immunity after yellow fever vaccination: systematic review on the need for a booster every 10 years.

Review of the risks and benefits of yellow fever vaccination including some new analyses.

Second European evidence-based consensus on the prevention, diagnosis and management of opportunistic infections in inflammatory bowel disease.

Yellow fever vaccine: recommendations of the Advisory Committee on Immunization Practices (ACIP).

Comparison of the PRNT and an immune fluorescence assay in yellow fever vaccinees receiving immunosuppressive medication.

Persistent seropositivity for yellow fever in a previously vaccinated autologous hematopoietic stem cell transplantation recipient.

Yellow Fever Vaccination of a Primary Vaccinee During Adalimumab Therapy.

Yellow fever revaccination during infliximab therapy.

Development of viremia and humoral and cellular parameters of immune activation after vaccination with yellow fever virus strain 17D: a model of human flavivirus infection.

P31

scholarly article

case report

P356

10.1136/BCR-2016-215403

http://www.w3.org/2001/XMLSchema#string

P478

2016

http://www.w3.org/2001/XMLSchema#string

P50

Nina Friis-Møller

P577

2016-08-29T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

27571912

http://www.w3.org/2001/XMLSchema#string

P921

yellow fever virus

P932

5015127

http://www.w3.org/2001/XMLSchema#string